Analytical Data
-
Gene name
APOC2
- Application
-
Alternative Names
APC2; Apo-C2; ProapoC-II; Apolipoprotein C-II; Proapolipoprotein C-II
-
Species
Rat
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
G3V8D4
-
Expression Region
Thr23~Glu97
-
Molecular Weight
41kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
APOC2 (Apolipoprotein C-II) is a key protein involved in lipid metabolism and plays a crucial role in the regulation of triglyceride levels in plasma. It is primarily synthesized in the liver and is found as a component of chylomicrons and very low-density lipoproteins (VLDL). The study of APOC2 recombinant protein has gained significance due to its implications in cardiovascular diseases and metabolic disorders, particularly hypertriglyceridemia. Variants of the APOC2 gene have been associated with altered lipid profiles and increased risk of atherosclerosis. The recombinant production of APOC2 allows for detailed functional studies, including its interactions with other proteins and lipoproteins, as well as its impact on lipoprotein metabolism. Furthermore, understanding the structural and functional characteristics of APOC2 can contribute to the development of therapeutic strategies aimed at modulating lipid levels, ultimately reducing the incidence of associated diseases. Research on APOC2 recombinant protein thus not only enhances our understanding of lipid metabolism but also opens avenues for innovative treatments in managing dyslipidemia and improving cardiovascular health.
